Cost Effectiveness of Cholinesterase Inhibitors in the Treatment of Alzheimer's Disease: A Review with Methodological Considerations

Author： Wimo A.  

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.21, Iss.5, 2004-01, pp. : 279-295

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Modelling the Cost Effectiveness of Cholinesterase Inhibitors in the Management of Mild to Moderately Severe Alzheimer's Disease

By Green Colin   Picot Joanna   Loveman Emma   Takeda Andrea   Kirby Jo   Clegg Andrew  

PharmacoEconomics, Vol. 23, Iss. 12, 2005-01 ,pp. : 1271-1282

Adis International

Access to resources Recommend Favorite

Modelling the Cost Effectiveness of Cholinesterase Inhibitors in the Management of Mild to Moderately Severe Alzheimer's Disease

By Bosanquet Nick  

PharmacoEconomics, Vol. 24, Iss. 6, 2006-01 ,pp. : 623-625

Adis International

Access to resources Recommend Favorite

Pharmacoeconomics of Cholinesterase Inhibitors in the Treatment of Alzheimer’s Disease

By Jönsson L.  

PharmacoEconomics, Vol. 21, Iss. 14, 2003-01 ,pp. : 1025-1037

Adis International

Access to resources Recommend Favorite

Cholinesterase Inhibitors for the Treatment of Alzheimer's Disease in the Elderly

By vandenBerg C.M.   Kazmi Y.   Jann M.W.  

Drugs & Aging, Vol. 16, Iss. 2, 2000-02 ,pp. : 123-138

Adis International

Access to resources Recommend Favorite

Cholinesterase Inhibitors for Alzheimer's Disease

By Grutzendler J.   Morris J.C.  

Drugs, Vol. 61, Iss. 1, 2001-01 ,pp. : 41-52

Adis International

Access to resources Recommend Favorite